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Iranian J Parasitol: Vol.  5 , No. 3 , 20 10 , pp .   69 - 70     69                   Letter to the Editor       Malaria vivax and Severe Thrombocytopenia in Iran     * M Metanat , B Sharifi - Mood        Research Center for Infectious Diseases and Tropical Medicine, Zahedan University of Medical Sc i ences,  Za hedan, Iran       ’                        Dear Editor in Chief   Iranian J Parasitol     Malaria vivax is prevalent in many regions  of the world. It is more prevalent in Asia and  Latin America and  accounts for  more than  half of all malaria cases in these two regions.  Clinically s e vere cases and c omplications of  malaria  are  commonly  due  to  Plasmodium  falciparum.   Hemat o logical  changes  are  nearly common in  malaria infection  but s e - vere t hrombocytopenia   is rare in  P.   vivax  (1,  2).  For  many  years,  malaria  infection  has  been  prevalent  in  Sistan  and  Balu chestan  Province, southeast Iran, and we have faced  with many cases of  P. vivax . However, until  2008,  we  had  not  observed  severe  thromb o cy topenia due to this malaria in the  area.  During  the  two  last  years  from  Aug  2007 to Sep 2009, we faced with some  peo - ple  along  the  Iran - Pakistan  and  Iran - Afghani stan bo r ders, and even in the Sistan  & Baluchestan  Province  in Iran, who had  severe thromb o cytopenia caused by  P. vivax .    We evaluated all patients who were referred  to our hospital in Zahedan because of vivax   malaria  during   2  years,  from  Aug  2007  to  Sep  2009 .  Out  of  the  34  patients  with  P.  vivax  (9 females, 25 males; age range: 14 -   58 years), 11 cases had a platelet count less  than 50000  and among them 7 patients had  a  platelet  count  below  20000,  2  cases  b e - t ween 10000 to 20000 and 5 cases less than  10000.  Patients who had platelet count less  than 10000 had small he m orrhages under the  skin and they underwent platelet transfusion.   Although,  severe  complications  including  profound   thrombocytopenia  are  common  du e to   falc i parum malaria  ( 3, 4) but, at now,  we are facing with severe thrombocytopenia  due to  vivax  m a laria. It may be due to a new  genotype of  P. vivax .  Non - immunological or  immunological  d e struction  of  platelets  are  given reason for  causing thrombocytop enia  Ira nian J Parasitol     Open access Journal at   http:// ijpa.tums.ac.ir       * Correspond ing Author:  Fax: +98/541/ 3212975   ;    E - mail:  malihemetanat@yahoo.com               Iranian Society of Paras ito l ogy   http:// isp.tums.ac.ir     Iranian J Parasitol     Open access Journal at   http:// ijpa.tums.ac.ir       Tehran University of Med i cal  Sciences Public a tion   http:// tums.ac.ir      Metanat and Sharifi - Mood.   Malaria vivax and Severe Thrombocyt o penia …   70   in such cases but the exact mechanisms in - volved are still not completely clear  (2). Fu r - ther studies are required to clarify the exact  mechanism  of  severe  thrombocytopenia  e s pe cially in  P. vivax .     References       1 .   Makkar  RP,  Mukhopadhyay  S,  Monga  A, Gu pta AK .    Plasm o dium   vivax  malaria presenting with se vere  thrombocytopenia.  Brazilian  J  Infec  Dis.  2002;6(5):263 - 265.   2 .   2 - Aggarwal  A,  Rath  S,  Shashiraj.  Plasmodium vivax  malaria presenting  with  severe  thrombocytopenia.  J  Trop Ped i atr. 2005 51(2):120 - 121.   3 .   Ja mal A,   Memon  I A,   Lateef  F. The  association of  Plasmodium vivax  ma - laria  with  thrombocytopenia  in  fe b - rile  children.  Pak  Paed  J.  Jun  2007;31(2):85 - 9.   4 .   Kaur D, Wasir V, Gulati SH, Bagga  A.   Unusual Presentation of  Plasm o - dium  vivax   malaria  with  severe  throm b o cytopenia  and  acute  renal  fail ure.  J  Trop  Pe diatr.   2007;  doi:10.1093/tropej/fml09    